US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 3.160
  • -0.380-10.73%
Close Mar 28 16:00 ET
  • 3.160
  • 0.0000.00%
Post 16:01 ET
76.99MMarket Cap-1.17P/E (TTM)

Artiva Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-16.03%-55.03M
-37.24%-14.65M
-8.03%-11.61M
-16.33%-13.69M
-5.92%-15.09M
6.69%-47.43M
-10.68M
-10.75M
-11.76M
-47.38%-14.24M
Net income from continuing operations
-127.62%-65.37M
-34.15%-16.1M
-254.91%-17.47M
-58.13%-17.84M
16.47%-13.96M
51.15%-28.72M
---12M
--11.28M
---11.28M
-37.88%-16.72M
Operating gains losses
408.77%3.6M
--0
--977K
--2.35M
--268K
--707K
----
----
----
----
Depreciation and amortization
7.28%2.43M
3.37%614K
12.77%627K
12.08%603K
1.56%587K
95.68%2.27M
--594K
--556K
--538K
246.11%578K
Change In working capital
98.85%-325K
71.39%-311K
112.65%3.01M
99.80%-7K
-4,812.50%-3.02M
-631.51%-28.28M
---1.09M
---23.8M
---3.46M
-93.11%64K
-Change in receivables
230.63%1.61M
-67.66%555K
231.26%760K
116.91%262K
104.26%35K
-2,064.91%-1.23M
--1.72M
---579K
---1.55M
-9.89%-822K
-Change in prepaid assets
-480.81%-1.97M
-19.27%176K
-94.43%-1.5M
-77.39%296K
-291.63%-936K
167.54%516K
--218K
---772K
--1.31M
72.14%-239K
-Change in payables and accrued expense
89.39%-140K
39.63%-1.07M
210.19%3.81M
53.74%-681K
-411.22%-2.19M
-114.63%-1.32M
---1.78M
--1.23M
---1.47M
-77.83%704K
-Change in other current assets
-10.07%125K
-31.11%31K
3.23%32K
3.33%31K
-6.06%31K
214.88%139K
--45K
--31K
--30K
--33K
-Change in other working capital
100.16%43K
100.08%1K
99.63%-88K
104.78%85K
-88.40%45K
-1,007.05%-26.38M
---1.29M
---23.7M
---1.78M
160.53%388K
Cash from discontinued investing activities
Operating cash flow
-16.03%-55.03M
-37.24%-14.65M
-8.03%-11.61M
-16.33%-13.69M
-5.92%-15.09M
6.69%-47.43M
---10.68M
---10.75M
---11.76M
-47.38%-14.24M
Investing cash flow
Cash flow from continuing investing activities
-363.77%-120.46M
63.79%-966K
-26,396.55%-130.63M
106.44%1.35M
625.35%9.78M
-312.37%-25.98M
-2.67M
-493K
-20.95M
-209.30%-1.86M
Net PPE purchase and sale
80.29%-642K
89.94%-64K
46.37%-96K
20.14%-464K
99.03%-18K
48.28%-3.26M
---636K
---179K
---581K
-209.30%-1.86M
Net investment purchase and sale
-427.45%-119.82M
55.61%-902K
-41,470.70%-130.53M
108.90%1.81M
--9.8M
---22.72M
---2.03M
---314K
---20.37M
--0
Cash from discontinued investing activities
Investing cash flow
-363.77%-120.46M
63.79%-966K
-26,396.55%-130.63M
106.44%1.35M
625.35%9.78M
-312.37%-25.98M
---2.67M
---493K
---20.95M
-209.30%-1.86M
Financing cash flow
Cash flow from continuing financing activities
565.11%162.23M
-103.12%-30K
599.38%163.87M
-16,260.00%-1.62M
0
2,029.67%24.39M
962K
23.43M
10K
96.07%-12K
Net issuance payments of debt
---149K
---33K
---38K
----
----
--0
--0
--0
----
----
Net common stock issuance
1,352,800.00%162.32M
---4.18M
--166.51M
--0
--0
-140.00%-12K
--0
--0
--0
---12K
Proceeds from stock option exercised by employees
410.00%51K
--23K
--6K
----
----
-96.99%10K
--0
--0
----
----
Net other financing activities
----
----
---2.6M
----
----
1,633.19%24.39M
--962K
----
----
----
Cash from discontinued financing activities
Financing cash flow
565.11%162.23M
-103.12%-30K
599.38%163.87M
-16,260.00%-1.62M
--0
2,029.67%24.39M
--962K
--23.43M
--10K
96.07%-12K
Net cash flow
Beginning cash position
-47.69%53.76M
-15.12%56.14M
-36.04%34.51M
-44.08%48.46M
-47.69%53.76M
-36.23%102.78M
--66.14M
--53.95M
--86.66M
-36.23%102.78M
Current changes in cash
72.93%-13.27M
-26.37%-15.65M
77.47%21.63M
57.34%-13.95M
67.09%-5.3M
16.06%-49.01M
---12.38M
--12.19M
---32.71M
-52.46%-16.12M
End cash Position
-24.68%40.49M
-24.68%40.49M
-15.12%56.14M
-36.04%34.51M
-44.08%48.46M
-47.69%53.76M
--53.76M
--66.14M
--53.95M
-42.46%86.66M
Free cash flow
-9.84%-55.67M
-30.09%-14.71M
-7.14%-11.71M
-14.61%-14.15M
6.22%-15.1M
11.27%-50.69M
---11.31M
---10.93M
---12.35M
-56.88%-16.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -16.03%-55.03M-37.24%-14.65M-8.03%-11.61M-16.33%-13.69M-5.92%-15.09M6.69%-47.43M-10.68M-10.75M-11.76M-47.38%-14.24M
Net income from continuing operations -127.62%-65.37M-34.15%-16.1M-254.91%-17.47M-58.13%-17.84M16.47%-13.96M51.15%-28.72M---12M--11.28M---11.28M-37.88%-16.72M
Operating gains losses 408.77%3.6M--0--977K--2.35M--268K--707K----------------
Depreciation and amortization 7.28%2.43M3.37%614K12.77%627K12.08%603K1.56%587K95.68%2.27M--594K--556K--538K246.11%578K
Change In working capital 98.85%-325K71.39%-311K112.65%3.01M99.80%-7K-4,812.50%-3.02M-631.51%-28.28M---1.09M---23.8M---3.46M-93.11%64K
-Change in receivables 230.63%1.61M-67.66%555K231.26%760K116.91%262K104.26%35K-2,064.91%-1.23M--1.72M---579K---1.55M-9.89%-822K
-Change in prepaid assets -480.81%-1.97M-19.27%176K-94.43%-1.5M-77.39%296K-291.63%-936K167.54%516K--218K---772K--1.31M72.14%-239K
-Change in payables and accrued expense 89.39%-140K39.63%-1.07M210.19%3.81M53.74%-681K-411.22%-2.19M-114.63%-1.32M---1.78M--1.23M---1.47M-77.83%704K
-Change in other current assets -10.07%125K-31.11%31K3.23%32K3.33%31K-6.06%31K214.88%139K--45K--31K--30K--33K
-Change in other working capital 100.16%43K100.08%1K99.63%-88K104.78%85K-88.40%45K-1,007.05%-26.38M---1.29M---23.7M---1.78M160.53%388K
Cash from discontinued investing activities
Operating cash flow -16.03%-55.03M-37.24%-14.65M-8.03%-11.61M-16.33%-13.69M-5.92%-15.09M6.69%-47.43M---10.68M---10.75M---11.76M-47.38%-14.24M
Investing cash flow
Cash flow from continuing investing activities -363.77%-120.46M63.79%-966K-26,396.55%-130.63M106.44%1.35M625.35%9.78M-312.37%-25.98M-2.67M-493K-20.95M-209.30%-1.86M
Net PPE purchase and sale 80.29%-642K89.94%-64K46.37%-96K20.14%-464K99.03%-18K48.28%-3.26M---636K---179K---581K-209.30%-1.86M
Net investment purchase and sale -427.45%-119.82M55.61%-902K-41,470.70%-130.53M108.90%1.81M--9.8M---22.72M---2.03M---314K---20.37M--0
Cash from discontinued investing activities
Investing cash flow -363.77%-120.46M63.79%-966K-26,396.55%-130.63M106.44%1.35M625.35%9.78M-312.37%-25.98M---2.67M---493K---20.95M-209.30%-1.86M
Financing cash flow
Cash flow from continuing financing activities 565.11%162.23M-103.12%-30K599.38%163.87M-16,260.00%-1.62M02,029.67%24.39M962K23.43M10K96.07%-12K
Net issuance payments of debt ---149K---33K---38K----------0--0--0--------
Net common stock issuance 1,352,800.00%162.32M---4.18M--166.51M--0--0-140.00%-12K--0--0--0---12K
Proceeds from stock option exercised by employees 410.00%51K--23K--6K---------96.99%10K--0--0--------
Net other financing activities -----------2.6M--------1,633.19%24.39M--962K------------
Cash from discontinued financing activities
Financing cash flow 565.11%162.23M-103.12%-30K599.38%163.87M-16,260.00%-1.62M--02,029.67%24.39M--962K--23.43M--10K96.07%-12K
Net cash flow
Beginning cash position -47.69%53.76M-15.12%56.14M-36.04%34.51M-44.08%48.46M-47.69%53.76M-36.23%102.78M--66.14M--53.95M--86.66M-36.23%102.78M
Current changes in cash 72.93%-13.27M-26.37%-15.65M77.47%21.63M57.34%-13.95M67.09%-5.3M16.06%-49.01M---12.38M--12.19M---32.71M-52.46%-16.12M
End cash Position -24.68%40.49M-24.68%40.49M-15.12%56.14M-36.04%34.51M-44.08%48.46M-47.69%53.76M--53.76M--66.14M--53.95M-42.46%86.66M
Free cash flow -9.84%-55.67M-30.09%-14.71M-7.14%-11.71M-14.61%-14.15M6.22%-15.1M11.27%-50.69M---11.31M---10.93M---12.35M-56.88%-16.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Abits
ABTS
+3.71%
Digihost Technology
DGHI
0.00%
Ebang International
EBON
-0.25%
BIT Mining
BTCM
-0.56%
Canaan
CAN
-0.68%

Unlock the Full List